| Full Name | Claire David |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 920 Avenue B, Marrero, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780272401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 10796 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeview Physical Therapy And Spine Llc | 6406187574 | 2 |
News Archive
WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.
"The President today made available to all Americans the Administration's health insurance reform proposal, which contains positive elements from the House and Senate-passed bills. I look forward to reviewing it with House Members and then joining the President and the Republican leadership at the Blair House meeting on Thursday. This discussion will continue a year-long historic level of transparency and open debate of this crucial reform effort.
Holiday dinners are filled with heaping dishes of comfort foods, fattening favorites and savory treats. It is no wonder these meals often leave us feeling stuffed with guilt and holiday remorse.
Results from a clinical study demonstrates that microwave measurements can be used for a rapid detection of intracranial bleeding in traumatic brain injuries.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.
› Verified 6 days ago
| Provider Name | Riverbend Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1427560721 PECOS PAC ID: 3173885472 Enrollment ID: O20180327000704 |
News Archive
WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.
"The President today made available to all Americans the Administration's health insurance reform proposal, which contains positive elements from the House and Senate-passed bills. I look forward to reviewing it with House Members and then joining the President and the Republican leadership at the Blair House meeting on Thursday. This discussion will continue a year-long historic level of transparency and open debate of this crucial reform effort.
Holiday dinners are filled with heaping dishes of comfort foods, fattening favorites and savory treats. It is no wonder these meals often leave us feeling stuffed with guilt and holiday remorse.
Results from a clinical study demonstrates that microwave measurements can be used for a rapid detection of intracranial bleeding in traumatic brain injuries.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.
› Verified 6 days ago
| Provider Name | Lakeview Physical Therapy And Spine Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1235791930 PECOS PAC ID: 6406187574 Enrollment ID: O20191004000649 |
News Archive
WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.
"The President today made available to all Americans the Administration's health insurance reform proposal, which contains positive elements from the House and Senate-passed bills. I look forward to reviewing it with House Members and then joining the President and the Republican leadership at the Blair House meeting on Thursday. This discussion will continue a year-long historic level of transparency and open debate of this crucial reform effort.
Holiday dinners are filled with heaping dishes of comfort foods, fattening favorites and savory treats. It is no wonder these meals often leave us feeling stuffed with guilt and holiday remorse.
Results from a clinical study demonstrates that microwave measurements can be used for a rapid detection of intracranial bleeding in traumatic brain injuries.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claire David, 920 Avenue B, Marrero, LA 70072-3112 Ph: () - | Claire David, 920 Avenue B, Marrero, LA 70072-3112 Ph: (504) 349-6804 |
News Archive
WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.
"The President today made available to all Americans the Administration's health insurance reform proposal, which contains positive elements from the House and Senate-passed bills. I look forward to reviewing it with House Members and then joining the President and the Republican leadership at the Blair House meeting on Thursday. This discussion will continue a year-long historic level of transparency and open debate of this crucial reform effort.
Holiday dinners are filled with heaping dishes of comfort foods, fattening favorites and savory treats. It is no wonder these meals often leave us feeling stuffed with guilt and holiday remorse.
Results from a clinical study demonstrates that microwave measurements can be used for a rapid detection of intracranial bleeding in traumatic brain injuries.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.
› Verified 6 days ago
Dr. Marjorie Ann Ryan, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4519 Westbank Expy, Marrero, LA 70072 Phone: 504-349-6140 | |
Connie Frost, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4633 Wichers Dr, Marrero, LA 70072 Phone: 504-347-0733 Fax: 504-378-9329 | |
Alexa Landry, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7520 Westbank Expy Ste D, Marrero, LA 70072 Phone: 504-371-4226 | |
Lane Taylor Macdougall, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 Medical Center Blvd Ste 630, Marrero, LA 70072 Phone: 504-340-6976 | |
Jill P Nguyen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1250 Burgess Drive, Marrero, LA 70072 Phone: 832-771-7028 | |
Karen Cannella, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 Medical Center Blvd Ste S630, Marrero, LA 70072 Phone: 504-340-6976 Fax: 504-934-8044 | |
Mindy Huynh Le, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 Medical Center Blvd Ste S630, Marrero, LA 70072 Phone: 504-340-6976 Fax: 504-834-8044 |